Literature DB >> 7536128

Expression of the prostate-specific antigen gene by a primary ovarian carcinoma.

H Yu1, E P Diamandis, M Levesque, S L Asa, M Monne, C M Croce.   

Abstract

We describe a patient with primary ovarian carcinoma that developed after liver transplantation whose tumor was highly positive for prostate-specific antigen (PSA). PSA in tumor tissue was characterized by two immunoassays, HPLC, immunohistochemistry, reverse transcription-PCR, Southern blotting, and DNA sequencing. PSA in the ovarian tumor was present as free, M(r) 33,000 protein (> 90%) and as PSA bound to alpha 1-antichymotrypsin (M(r) 100,000; < 10%). Immunohistochemistry localized PSA in the cytoplasm of epithelial cells of the tumor. Two separate reverse transcription-PCRs for PSA amplified the expected products which hybridized specifically to a PSA cDNA probe on Southern blots. Sequencing of the PCR products, representing the whole coding sequence of the PSA gene, revealed identity with the sequence of PSA cDNA from prostate tissue. These data suggest that the PSA produced by the ovarian tumor was identical in molecular weight and sequence to prostatic PSA. Based on data of tissue culture experiments with breast carcinoma cell lines, we speculate that the PSA gene in the tumor of this patient was up-regulated by the therapeutically administered glucocorticoids after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536128

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.

Authors:  H Yu; E P Diamandis; M Levesque; M Giai; R Roagna; R Ponzone; P Sismondi; M Monne; C M Croce
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.

Authors:  A Burelli; R Cionini; E Rinaldi; E Benelli; E Fiore; D Canale; W Bencivelli; C Nencetti; A Pinchera; E Pucci
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

3.  Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer?

Authors:  H B Goldman; R S Israeli; Y Lu; J L Lerner; R S Hollabaugh; M S Steiner
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

5.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.

Authors:  H Yu; M A Levesque; G M Clark; E P Diamandis
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.

Authors:  J A Foekens; E P Diamandis; H Yu; M P Look; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.

Authors:  S Majumdar; E P Diamandis
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy.

Authors:  Nobuki Furubayashi; Takahito Negishi; Yu Hirata; Kenichi Taguchi; Mototsugu Shimokawa; Motonobu Nakamura
Journal:  Oncol Lett       Date:  2014-09-01       Impact factor: 2.967

10.  Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours.

Authors:  R E Hall; J A Clements; S N Birrell; W D Tilley
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.